“A Lower Confidence Limit for the Benchmark Dose Using Higher Order Inference”, in Joint Statistical Meeting, Boston, MA, 2014.
, “Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
, “Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster).”, in NCI ASCO Cancer Trials Accrual Symposium, Bethesda, MD, 2010.
, “Monitoring Medication Adherence Electronically: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)”, presented at the 2011, Honolulu, Hawaii, 2011.
, “Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (HSCT).”, in American Society of Hematology 52nd Annual Meeting and Exposition, Orlando, Fl, 2010.
, “A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
, “The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations”, in The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations., Baltimore, MD, 2019.
, “The National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements (CDE]): What They Are, Ways to Use Them, and Gaps, Mini-Symposium”, in American Academy for Cerebral Palsy and Developmental Medicine 77th Annual Meeting, Chicago, IL, 2023.
, “The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)”, in Society for Clinical Trials, Montreal, Canada, 2007.
, “The National Institute of Neurological Disorders and Stroke (NINDS) Updates to the Cerebral Palsy Common Data Elements Version 1.0 Recommendations”, in American Academy of Neurology 72nd Annual Virtual Meeting, Virtual, 2020.
, “Natural Course of Egg, Milk and Peanut Allergy Using a Novel Diagnostic Scheme: 1 Year Follow-Up in an Observational Study (CoFAR2) of Food Allergy”, in 2009 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, Washington DC, 2009, vol. 123:2, p. S177.
, “The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact”, in 2007 ASCO Annual Meeting, 2007, 18 Supplement 6632th ed., vol. 25.
, “Neonatal Outcomes in the MONEAD Study of Pregnant Women with Epilepsy”, in Pediatric Academic Socities (PAS), 2021.
, “Neurological Evaluations within the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA)”, in Undersea and Hyperbaric Medical Society Annual Scientific Meeting; Military Health System Research Symposium, 2014.
, “A New Study Methodology: ADAPT, The Short, Staged Trial”, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
, “NIDA Clinical Trials Network (CTN) Electronic Health Records Project: Public Opportunity for Input into Standardized Common Data Elements for Drug Abuse Treatment”, in 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA), Boston, MA, 2011.
, “NIH/NHLBI-Funded Program Production Assistance For Cellular Therapies (PACT) Renewed.”, in Transfusion, Baltimore, MD., 2010, vol. 50, p. SP458.
, “The NINDS Clinical Research Collaboration”, in American Academy of Neurology, Miami, FL, 2005.
, “NINDS Clinical Research Collaboration Colloquium: Neurology Research Needs You!”, in American Academy of Neurology, Boston, MA, 2007.
, “A Novel and Efficient Site Selection Process for a Large Multi-Center Trial”, in 27th Annual Meeting for the Society for Clinical Trials, Orlando, FL, 2006.
, “A Novel Scoring System, The Cord Blood APGAR, Predicts Engraftment after Cord Blood Transplantation: Optimization of Selection of CBUs for Transplantation.”, in ISCT 2010, Philadelphia, PA, 2010.
, “Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC)”, in Advancing Science of Clinical Oncology Annual Meeting, Orlando, FL, 2005.
, “Ongoing Prospective Multicenter Safety Study of Subcutaneous Cytoprotectant Amifostine for Head and Neck Carcinoma”, in 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Denver, CO, 2005.
, “Operational Data Management within the Clinical Trials Network of the National Institute on Drug Abuse (NIDA CTN)”, in 20th Annual Conference of the Society for Clinical Data Management, Las Vegas, NV, 2014.
,